A carregar...
Improvement in patient-reported hearing after treatment with bevacizumab in people with Neurofibromatosis Type 2
OBJECTIVE: Assess patient-reported outcomes (PRO) for hearing and tinnitus relative to clinical hearing assessment in people with neurofibromatosis 2 (NF2) associated hearing loss. STUDY DESIGN: Prospective, open label, phase-II clinical trial with PRO administered pre-, post- and after treatment. S...
Na minha lista:
| Publicado no: | Otol Neurotol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6642810/ https://ncbi.nlm.nih.gov/pubmed/29649040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MAO.0000000000001781 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|